The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Surface modifications of nanoparticles and their suitability for studying gastrointestinal diseases
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This aggregation leads to inconsistent biodistribution and affects their ability to effectively target tumor sites.”
From Advances in green-synthesized magnetic nanoparticles for targeted cancer therapy: mechanisms, applications, and future perspectives (2026) · cites this paper as [101]
In the citing paper
“To mitigate this, surface modifications such as PEGylation or the use of stabilizing agents like dextran have been employed, but these solutions are not universally effective [101].”
From Advances in green-synthesized magnetic nanoparticles for targeted cancer therapy: mechanisms, applications, and future perspectives (2026) · cites this paper as [101]
In the citing paper
“The presence of proteins in the blood can cause nonspecific binding to nanoparticles, reducing their stability and effectiveness.”
From Advances in green-synthesized magnetic nanoparticles for targeted cancer therapy: mechanisms, applications, and future perspectives (2026) · cites this paper as [101]
In the citing paper
“Upon intravenous administration, MNPs are subject to aggregation due to van der Waals forces and magnetic interactions.”
From Advances in green-synthesized magnetic nanoparticles for targeted cancer therapy: mechanisms, applications, and future perspectives (2026) · cites this paper as [101]
In the citing paper
“Instability in Blood Circulation remains a significant issue.”
From Advances in green-synthesized magnetic nanoparticles for targeted cancer therapy: mechanisms, applications, and future perspectives (2026) · cites this paper as [101]
Citations
Cites
Yue, N.-N., Xu, H.-M., Xu, J., Zhu, M.-Z., Zhang, Y., Tian, C.-M., Nie, Y.-Q., Yao, J., Liang, Y.-J., Li, D.-F., et al. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s413141 · Cited by 46
Flagged first, then by citations
Research works printed but not linked: 65
- Garbati, 2024, Targeting the gut: a systematic review of specific drug nanocarriers, Pharmaceutics, 16, 10.3390/pharmaceutics16030431 · DOI
- Kanaoujiya, 2022, Applications of nanomaterials for gastrointestinal tumors: a review, Front. Med. Technol., 4, 1, 10.3389/fmedt.2022.997123 · DOI
- Ly, 2024, Recent advances in surface decoration of nanoparticles in drug delivery, Front. Nanotechnol., 6, 10.3389/fnano.2024.1456939 · DOI
- Ensign, 2012, Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers, Adv. Drug. Deliv. Rev., 64, 557, 10.1016/j.addr.2011.12.009 · DOI
- Sato, 2023, Recent advancements in the development of nanocarriers for mucosal drug delivery systems to control oral absorption, Pharmaceutics, 15, 2708, 10.3390/pharmaceutics15122708 · DOI
- Pauly, 2015, Surface modification of alumina-coated silica nanoparticles in aqueous sols with phosphonic acids and impact on nanoparticle interactions, Phys. Chem. Chem. Phys., 17, 19173, 10.1039/C5CP01925G · DOI
- Vert, 2012, Terminology for biorelated polymers and applications (IUPAC recommendations 2012), Pure Appl. Chem, 84, 377, 10.1351/PAC-REC-10-12-04 · DOI
- Kaymaz, 2023, Nanomaterial surface modification toolkit: principles, components, recipes, and applications, Adv. Colloid Interface Sci., 322, 10.1016/j.cis.2023.103035 · DOI
- Shoaib, 2023, A nanotechnology-based approach to biosensor application in current diabetes management practices, Nanomaterials, 13, 10.3390/nano13050867 · DOI
- Sim, 2021, Nanotechnology and its use in imaging and drug delivery (review), Biomed. Rep., 14, 10.3892/br.2021.1418 · DOI
- Han, 2019, Applications of nanoparticles in biomedical imaging, Nanoscale, 11, 799, 10.1039/C8NR07769J · DOI
- Hotze, 2010, Nanoparticle aggregation: challenges to understanding transport and reactivity in the environment, J. Environ. Qual., 39, 1909, 10.2134/jeq2009.0462 · DOI
- Suk, 2016, PEGylation as a strategy for improving nanoparticle-based drug and gene delivery, Adv. Drug. Deliv. Rev., 99, 28, 10.1016/j.addr.2015.09.012 · DOI · Paper page
- Shi, 2021, Effects of polyethylene glycol on the surface of nanoparticles for targeted drug delivery, Nanoscale, 13, 10748, 10.1039/D1NR02065J · DOI
- Kostiv, 2017, Physico-chemical characteristics, biocompatibility, and MRI applicability of novel monodisperse PEG-modified magnetic Fe3O4&SiO2 core-shell nanoparticles, RSC Adv., 7, 8786, 10.1039/C7RA00224F · DOI
- Wang, 2020, Enhanced dispersion stability of gold nanoparticles by the physisorption of cyclic poly(ethylene glycol), Nat. Commun., 11, 6089, 10.1038/s41467-020-19947-8 · DOI
- Han, 2018, The influence of functionalization of the Fe3O4 nanoparticle on its dispersion property, J. Korean Ceram. Soc., 55, 80, 10.4191/kcers.2018.55.1.01 · DOI
- Sabzi Dizajyekan, 2024, Preparation of stable colloidal dispersion of surface modified Fe3O4 nanoparticles for magnetic heating applications, Sci. Rep., 14, 10.1038/s41598-024-51801-5 · DOI
- Alcantara, 2024, A promising strategy of surface-modified nanoparticles targeting CXCR4 for precision cancer therapy, J. Drug Targeting, 32, 587, 10.1080/1061186X.2024.2345235 · DOI
- Lee, 2020, Exploring maleimide-based nanoparticle surface engineering to control cellular interactions, ACS Appl. Nano Mater., 3, 2421, 10.1021/acsanm.9b02541 · DOI
- Azam Ali, 2019, Surface modification and bioconjugation of nanoparticles for MRI technology surface modification of nanoparticles for targeted drug delivery, Springer International Publishing, New Zealand, 405
- Hua, 2012, A novel route to copper(ii) detection using ‘click’ chemistry-induced aggregation of gold nanoparticles, Analyst, 137, 82, 10.1039/C1AN15693D · DOI
- Mugaka, 2019, Surface modification of gold nanoparticles for targeted drug delivery. In, Surface Modification Of Nanoparticles For Targeted Drug Delivery, 391, 10.1007/978-3-030-06115-9_20 · DOI
- Sun, 2006, “Clickable” nanoparticles for targeted imaging, Mol. Imaging, 5, 122, 10.2310/7290.2006.00013 · DOI
- Maltzahn, 2008, In vivo tumor cell targeting with “Click” nanoparticles, Bioconjugate Chem., 19, 1570, 10.1021/bc800077y · DOI
- Hein, 2008, Click chemistry, a powerful tool for pharmaceutical sciences, Pharm. Res., 25, 2216, 10.1007/s11095-008-9616-1 · DOI
- Ehsani, 2021, Immobilization of recombinant lysostaphin on nanoparticle through biotin–streptavidin conjugation technology as a geometrical progressed confrontation against Staphylococcus aureus infection, Biotechnol. Appl. Biochem., 68, 1058, 10.1002/bab.2025 · DOI
- Nguyen, 2022, Pharmacokinetics and pharmacodynamics of intranasal solid lipid nanoparticles and nanostructured lipid carriers for nose-to-brain delivery, Pharmaceutics, 14, 572, 10.3390/pharmaceutics14030572 · DOI
- De Sousa Delgado, 2000, Surface modification of polystyrene nanoparticles using dextrans and dextran-POE copolymers: polymer adsorption and colloidal characterization, J. Biomater. Sci. Polym. Ed., 11, 1395, 10.1163/156856200744309 · DOI
- Wang, 2020, Gadolinium-loaded solid lipid nanoparticles for colorectal tumor in MR colonography, J. Biomed. Nanotechnol., 16, 594, 10.1166/jbn.2020.2922 · DOI
- Yang, 2012, Functionalized mesoporous silica materials for controlled drug delivery, Chem. Soc. Rev., 41, 3679, 10.1039/c2cs15308d · DOI
- Tae-Jong, 2006, Specific targeting, cell sorting, and bioimaging with smart magnetic silica core–shell nanomaterials, Small, 2, 209, 10.1002/smll.200500360 · DOI
- Koole, 2008, Paramagnetic lipid-coated silica nanoparticles with a fluorescent quantum dot core: a new contrast agent platform for multimodality imaging, Bioconjugate Chem., 19, 2471, 10.1021/bc800368x · DOI
- Wang, 2011, Synthesis of magnetic, fluorescent and mesoporous core-shell-structured nanoparticles for imaging, targeting and photodynamic therapy, J. Mater. Chem., 21, 11244, 10.1039/c1jm10329f · DOI
- Deivayanai, 2024, A comprehensive review on advances in nanoparticle-mediated cancer therapeutics: current research and future perspectives, Cancer Pathog. Ther.
- Aikins, 2020, Engineered nanoparticles for cancer vaccination and immunotherapy, Acc. Chem. Res., 53, 2094, 10.1021/acs.accounts.0c00456 · DOI
- Vitulo, 2022, Interactions between nanoparticles and intestine, Int. J. Mol. Sci., 23, 4339, 10.3390/ijms23084339 · DOI
- Amara, 2019, Variations in gastrointestinal lipases, pH and bile acid levels with food intake, age and diseases: possible impact on oral lipid-based drug delivery systems, Adv. Drug. Deliv. Rev., 142, 3, 10.1016/j.addr.2019.03.005 · DOI
- Cueva, 2019, Gastrointestinal digestion of food-use silver nanoparticles in the dynamic SIMulator of the gastroIntestinal tract (simgi®), Food Chem. Toxicol., 132, 10.1016/j.fct.2019.110657 · DOI
- Zhao, 2019, Magnitude, risk factors, and factors associated with adenoma miss rate of tandem colonoscopy: a systematic review and meta-analysis,, Gastroenterology, 156, 1661, 10.1053/j.gastro.2019.01.260 · DOI · Paper page
- Miao, 2018, Organic semiconducting agents for deep-tissue molecular imaging: second near-infrared fluorescence, self-luminescence, and photoacoustics, Adv. Mater., 30, 10.1002/adma.201801778 · DOI
- Tong, 2015, Near-infrared fluorescent probes for imaging of amyloid plaques in alzheimer's disease, Acta Pharmaceutica Sinica. B, 5, 25, 10.1016/j.apsb.2014.12.006 · DOI
- Xu, 2018, Imaging of colorectal cancers using activatable nanoprobes with second near-infrared window emission, Angew. Chem. Int. Ed., 57, 3626, 10.1002/anie.201712528 · DOI
- Angelovski, 2016, What we can really do with bioresponsive MRI contrast agents, Angew. Chem. Int. Ed., 55, 7038, 10.1002/anie.201510956 · DOI
- Mao, 2016, Functional nanoparticles for magnetic resonance imaging, Wiley. Interdiscip. Rev. Nanomed. Nanobiotechnol., 8, 814, 10.1002/wnan.1400 · DOI
- Kobayashi, 2001, Dynamic micro-magnetic resonance imaging of liver micrometastasis in mice with a novel liver macromolecular magnetic resonance contrast agent DAB-Am64-(1B4M-Gd)64, Cancer Res., 61, 4966
- Pagoto, 2016, Paramagnetic phospholipid-based micelles targeting VCAM-1 receptors for MRI visualization of inflammation, Bioconjugate Chem., 27, 1921, 10.1021/acs.bioconjchem.6b00308 · DOI
- Li, 2017, Biocompatible PEGylated bismuth nanocrystals: “All-in-one” theranostic agent with triple-modal imaging and efficient in vivo photothermal ablation of tumors, Biomaterials, 141, 284, 10.1016/j.biomaterials.2017.06.033 · DOI
- Nishimura, 2006, Preoperative esophageal cancer staging: magnetic resonance imaging of lymph node with ferumoxtran-10, an ultrasmall superparamagnetic iron oxide, J. Am. Coll. Surg., 202, 604, 10.1016/j.jamcollsurg.2005.12.004 · DOI
- Wu, 2016, Nanoparticle-based imaging of inflammatory bowel disease, Wiley. Interdiscip. Rev. Nanomed. Nanobiotechnol., 8, 300, 10.1002/wnan.1357 · DOI
- Shi, 2019, Magnetic semiconductor Gd-Doping CuS nanoparticles as activatable nanoprobes for bimodal imaging and targeted photothermal therapy of gastric tumors, Nano Lett., 19, 937, 10.1021/acs.nanolett.8b04179 · DOI
- Bor, 2016, Role of ultrasound in colorectal diseases, World J. Gastroenterol., 22, 9477, 10.3748/wjg.v22.i43.9477 · DOI
- Chen, 2019, Acidic pH-Activated gas-generating nanoparticles with pullulan decorating for hepatoma-targeted ultrasound imaging, ACS Appl. Mater. Interfaces, 11, 22194, 10.1021/acsami.9b06745 · DOI
- Hu, 2020, NIRF Nanoprobes for cancer molecular imaging: approaching clinic, Trends Mol. Med., 26, 469, 10.1016/j.molmed.2020.02.003 · DOI
- Fan, 2013, Experimental investigation of the penetration of ultrasound nanobubbles in a gastric cancer xenograft, Nanotechnology, 24, 10.1088/0957-4484/24/32/325102 · DOI
- Lee, 2021, Imaging strategy that achieves ultrahigh contrast by utilizing differential esterase activity in organs: application in early detection of pancreatic cancer, ACS Nano, 15, 17348, 10.1021/acsnano.1c05165 · DOI
- Garrigue, 2018, Self-assembling supramolecular dendrimer nanosystem for PET imaging of tumors, Proc. Nat. Acad. Sci. U.S.A., 115, 11454, 10.1073/pnas.1812938115 · DOI
- Halwani, 2022, Development of pharmaceutical nanomedicines: from the bench to the market, Pharmaceutics, 14, 10.3390/pharmaceutics14010106 · DOI
- Salah, 2020, Solid lipid nanoparticles for enhanced oral absorption: A review, Colloids Surf. B, 196, 10.1016/j.colsurfb.2020.111305 · DOI
- Younes, 2021, Safety assessment of titanium dioxide (E171) as a food additive, EFSA J., 19, e06585
- Zhao, 2022, Recent advances in the development of noble metal NPs for cancer therapy, Bioinorg. Chem. Appl., 2022, 10.1155/2022/2444516 · DOI
- Ways, 2018, Chitosan and Its derivatives for application in mucoadhesive drug delivery systems, Polymers, 10, 267, 10.3390/polym10030267 · DOI
- Liang, 2023, Cell-derived nanovesicle-mediated drug delivery to the brain: principles and strategies for vesicle engineering, Mol. Ther., 31, 1207, 10.1016/j.ymthe.2022.10.008 · DOI · Paper page
- Blanco, 2015, Principles Of nanoparticle design for overcoming biological barriers to drug delivery, Nat. Biotechnol., 33, 941, 10.1038/nbt.3330 · DOI · Paper page
- Liu, 2022, Tracking tools of extracellular vesicles for biomedical research, Front. Bioeng. Biotechnol., 10, 10.3389/fbioe.2022.943712 · DOI
Cited by
Sorted by citations
El-khawaga, A. M., Youssef, O. I., El-dydamoni, O. A., Ragab, W. M., & Mohammed, R. A. E. (2026) · European Journal of Medical Research · doi:10.1186/s40001-025-03804-9 · Cited by 14
Metadata
- Authors
- Obasi, C. C., & Banigo, A. T.
- Venue
- Nano-Bio-Medicine for Gastrointestinal Diseases
- Publisher
- Elsevier
- Published
- 2026
- Pages
- 293-310
- Cited by
- 2
- References
- 1
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review